Home
Issues
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
2021
December - Vol 14, No 4
September - Vol 14 No 3
June - Vol 14, No 2
March - Vol 14 No 1
2020
October/November - Vol 13 No 5
September - Vol 13 No 4
June - Vol 13 No 3
May - Vol 13 No 2
February - Vol 13 No 1
Issue Archive
Value-Based Care in Cardiometabolic Health
Special Issues
2021 Special Issues
December - Twelfth Annual Payers' Guide
August - Vol 14, Special Issue: Payers' Perspectives in Oncology
February - Vol 14, Special Issue: Payers' Perspectives in Oncology
2020 Special Issues
Supplements
Special Issue Archive
Topics
Conference Correspondent
ASCO 2020 - Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
2021
December - Vol 14, No 4
September - Vol 14 No 3
June - Vol 14, No 2
March - Vol 14 No 1
2020
October/November - Vol 13 No 5
September - Vol 13 No 4
June - Vol 13 No 3
May - Vol 13 No 2
February - Vol 13 No 1
Issue Archive
Value-Based Care in Cardiometabolic Health
Special Issues
2021 Special Issues
December - Twelfth Annual Payers' Guide
August - Vol 14, Special Issue: Payers' Perspectives in Oncology
February - Vol 14, Special Issue: Payers' Perspectives in Oncology
2020 Special Issues
Supplements
Special Issue Archive
Topics
Conference Correspondent
ASCO 2020 - Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Mary Mosley
Authored Items
Intensive Treatment Early in Type 1 Diabetes Produces Substantial Long-Term Benefits
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Albiglutide, a GLP-1 Receptor Agonist, Effective in Various Treatment Scenarios in Patients with Type 2 Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
in
Emerging Therapies
Costs of Diabetes-Related Complications Reduced with Canagliflozin Monotherapy
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Resource Utilization and Costs: Comparing Saxagliptin and Sitagliptin
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Substantial Costs for Diabetes Are Consumed by the Diabetic Foot and Arthritis
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Specialized Team Approach and Education Improve Care, Save Money in Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Highlights from the ADA President’s Research Sessions
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Pooled Analysis Confirms CV Benefits of DPP-4 Inhibition
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Novel Predictors of Outcomes in Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Reductions in HbA1c Levels, Hypoglycemia, and Weight with Linagliptin in Patients with Type 2 Diabetes and Renal Impairment
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Lifestyle Intervention Beneficial in Patients with Diabetes, but Not for CV Parameters
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Hypertension: Highlights from ESC 2012
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
Aspirin Safely Omitted from Antithrombotic Therapy in Patients with AF Undergoing PCI
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
New Prognostic Markers in Hypertension Identified
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
PHS II: Cardiovascular Events in Men Not Reduced with Multivitamins
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Cardiometabolic Health
Third Definition of Myocardial Infarction Presented at ESC 2012, Focusing on New High-Sensitivity Biomarkers
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Cardiometabolic Health
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
Belly Fat Triples CV and All-Cause Mortality, Even with Normal Weight
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
UKPDS Follow-Up: Early HbA1c Reductions Linked to a Decrease in MI, All-Cause Mortality
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
Medical Costs Increase as Chronic Kidney Disease Worsens
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
ORIGIN: Insulin Glargine and Omega-3 Do Not Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Ninety Years of Insulin: What’s Needed? What’s New?
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
rHuPH20 Added to Rapid-Acting Insulin Noninferior to Lispro in Type 1 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Novel Risk Factors for Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Diabetic Retinopathy: Beneficial Effects Shown in Experimental Model with Linagliptin
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
TODAY Study: New Data, Implications for Young Patients with Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Emerging Therapies
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Emerging Therapies
Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
TODAY Study: New Data, Implications for Young Patients with Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Novel Risk Factors for Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Emerging Therapies
Ninety Years of Insulin: What’s Needed? What’s New?
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Emerging Therapies
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Medical Costs Increase as Chronic Kidney Disease Worsens
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
ORIGIN: Insulin Glargine and Omega-3 Do Not Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Diabetic Retinopathy: Beneficial Effects Shown in Experimental Model with Linagliptin
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
rHuPH20 Added to Rapid-Acting Insulin Noninferior to Lispro in Type 1 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
UKPDS Follow-Up: Early HbA1c Reductions Linked to a Decrease in MI, All-Cause Mortality
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Value of Remote Disease Management of Arrhythmia Highlighted at ACC 2012
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Faster, Safer Discharge from Emergency Department with Coronary CT Angiography
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Vorapaxar, a Novel Antithrombotic Agent, Reduces Events but Increases Bleeding
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Comparative Effectiveness Analysis of Coronary Bypass Surgery and Percutaneous Revascularization
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Dabigatran Safe and Effective Anticoagulant Postablation in Patients with Atrial Fibrillation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Advances in Stem-Cell Therapy for Heart Failure
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Comparative Effectiveness Analysis of Antithrombotics in Older Patients with Post-ACS Atrial Fibrillation
Mary Mosley
September/October 2011 Volume 4, Number 6
Comparative Effectiveness Analysis: Emergency Department CTA versus Standard ACS Symptom Evaluation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
New JNC-8 Hypertension Guidelines to Be Released by Year End
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
ACC Launches Legends of Cardiovascular Medicine Series
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Value-Based Purchasing: Cardiologists Urged to Move from Quantity to Quality of Care
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Coronary Computed Tomography Angiography Cost-Effective in CAD
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Cost-Effective Imaging: What Parameters Determine Value?
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Novel Oral Anticoagulants Reduce Total Medical Costs in Patients with Nonvalvular Atrial Fibrillation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Last modified: July 13, 2012
SUBSCRIBE
HOME
ABOUT
CONTACT US
TERMS OF USE
PRIVACY POLICY
ADVERTISING POLICY
Copyright © Amplity Medical Communications. All rights reserved.
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
AHDB
Print Edition
AHDB
Weekly e‑Newsletter
-- Please Select --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
AHDB
's
Privacy Policy
, and
AHDB
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION
